Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Alpine Immune Sciences's peak revenue was $58.9M in 2023. The peak quarterly revenue was $30.9M in 2023(q4).
Alpine Immune Sciences's revenue increased from $492.0k in 2017 to $58.9M currently. That's a 3,301.27% change in annual revenue.
| Fiscal year / year | Alpine Immune Sciences revenue |
|---|---|
| 2017 | $1.7M |
| 2018 | $705,000 |
| 2019 | $1.7M |
| 2020 | $9.3M |
| 2021 | $23.4M |
| 2022 | $30.1M |
| 2023 | $58.9M |
Rate Alpine Immune Sciences' financial transparency
Alpine Immune Sciences saw the greatest revenue growth in 2016, when revenue increased by 499.59%.
Alpine Immune Sciences had the lowest revenue growth in 2018, when revenue changed by -59.27%.
| Year | Alpine Immune Sciences growth |
|---|---|
| 2018 | -59%↓ |
| 2019 | 147%↑ |
| 2020 | 436%↑ |
| 2021 | 151%↑ |
| 2022 | 28%↑ |
| 2023 | 96%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2017 | - | - | $128,000 | $128,000 |
| 2018 | $315,000 | $390,000 | - | - |
| 2019 | - | $567,000 | $289,000 | $884,000 |
| 2020 | $1.1M | $688,000 | $1.9M | $5.6M |
| 2021 | $3.2M | $7.2M | $8.5M | $4.5M |
| 2022 | $13.6M | $5.3M | $8.4M | $2.8M |
| 2023 | $9.4M | $8.6M | $10.0M | $30.9M |
| 2024 | $7.0M | - | - | - |
Do you work at Alpine Immune Sciences?
Is Alpine Immune Sciences transparent about its revenue structure?
| CEO | Mitchell H. Gold M.d |
| Industry | Software & Services |
| Company Type | Public |
| Employees Number | 48 |
| Date Founded | 2015 |
| Headquarters | Seattle, Washington |
| Number of Locations | 1 |
| Revenue | $58.9M |
| Net Income | -$57,762,000 |
| Tax Rate | -0.0% |
| Total Assets | $286,686,000 |
| Ticker | ALPN |
Alpine Immune Sciences received early financing of $1.3M on 2015-01-23.
| Series | Round size | Date |
|---|---|---|
| Seed | $1.3M | 01/2015 |
| Series A | $48M | 06/2016 |
| Post Ipo Equity | $25M | 01/2019 |
| Post Ipo Equity | $60M | 07/2020 |
| Post Ipo Equity | $91M | 09/2021 |
| Investors | Security type |
|---|---|
| Alpine BioVentures GP LLC | Series A |
| Frazier Healthcare Partners | Series A |
| OrbiMed Advisors | Series A |
| Decheng Capital | Post Ipo Equity |
| Alpine BioVentures GP LLC | Post Ipo Equity |
| Frazier Healthcare Partners | Post Ipo Equity |
| Biotechnology Value Fund | Post Ipo Equity |
| OrbiMed Advisors | Post Ipo Equity |
| EcoR1 Capital LLC | Post Ipo Equity |
| Avidity Partners | Post Ipo Equity |
| Omega Funds | Post Ipo Equity |
| Samsara BioCapital | Post Ipo Equity |
| Logos Capital | Post Ipo Equity |
| BVF Partners | Post Ipo Equity |
| Decheng Capital | Post Ipo Equity |
| Avidity Partners | Post Ipo Equity |
| Frazier Healthcare Partners | Post Ipo Equity |
| Omega Funds | Post Ipo Equity |
| OrbiMed Advisors | Post Ipo Equity |
| TCG Crossover | Post Ipo Equity |
Zippia gives an in-depth look into the details of Alpine Immune Sciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Alpine Immune Sciences. The employee data is based on information from people who have self-reported their past or current employments at Alpine Immune Sciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Alpine Immune Sciences. The data presented on this page does not represent the view of Alpine Immune Sciences and its employees or that of Zippia.
Alpine Immune Sciences may also be known as or be related to ALPINE IMMUNE SCIENCES, INC., Alpine Immune Sciences, Alpine Immune Sciences Inc, Alpine Immune Sciences Inc. and Alpine Immune Sciences, Inc.